---

Dept of Health

Answer

Mrs. Ewing: To ask the Secretary of State for Health if he will list those countries in Europe and North America which license the MMR and those which license single vaccinations for mumps, measles and rubella. [149345] Yvette Cooper: All European Union member states and the United States of America recommend a two dose vaccination schedule with MMR vaccine. There is no comprehensive list available of measles, mumps and rubella combination vaccines, two-component vaccines or single component vaccines that are currently licensed in Europe and North America. The Medicines Control Agency has obtained the following information from The European Drug Index (1997 edition), from national compendia of licensed medicinal products in France, Germany, Switzerland and Sweden (1998 to 2000 editions), from the 2001 edition of the USA Physician's Desk Reference, and from two companies. While these references indicate that such products are currently licensed as listed in the named countries, it is not known whether or not they are on the market at the present time. In the EU and Switzerland There are combined measles, mumps and rubella vaccines currently licensed in all countries in the EU, including the United Kingdom. Measles plus rubella vaccines are licensed in at least Italy, Switzerland and the UK. Measles plus mumps vaccines are licensed in at least Germany, Portugal and Switzerland. At least one measles single component vaccine is licensed in Italy, Belgium, France, Germany, Austria, Netherlands, Switzerland, Portugal, Spain, Greece and the UK. At least one single component mumps vaccine is licensed in Italy, Belgium, Germany, Austria, Netherlands, Switzerland, Portugal and the UK. There are numerous single component rubella vaccines licensed across the EU, including the UK. In the USA There is one combined measles, mumps and rubella vaccine listed in the 2001 edition of the USA Physician's Desk Reference. Also licensed are a measles plus rubella vaccine, a measles plus mumps vaccine and single component vaccines for each of measles, mumps and rubella.

Secondary information

Type

Written question

Reference

149345; 365 c132-3W

Session

2000-01

Subjects

Licensing Vaccination MMR vaccine Measles Mumps North America

Link

View this Written question on www.publications.parliament.uk